Volume 59, Issue 5, Pages (May 2001)

Slides:



Advertisements
Similar presentations
Volume 66, Issue 4, Pages (October 2004)
Advertisements

Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Volume 58, Issue 5, Pages (November 2000)
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Plasma sodium and hypertension
Combination therapy with ACE inhibitors and angiotensin II receptor blockers in chronic renal disease: New therapeutic world beyond blood pressure reduction 
Volume 82, Issue 1, Pages 7-8 (July 2012)
Volume 58, Issue 5, Pages (November 2000)
Volume 12, Issue 5, Pages (November 2010)
Boye L. Jensen, Bianca Mann, Ole Skøtt, Armin Kurtz 
Volume 60, Issue 3, Pages (September 2001)
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine  Amato de Paulis,
Yihan Wang, Michael A. Shia, Thomas G. Christensen, Steven C. Borkan 
Volume 58, Issue 5, Pages (November 2000)
Membranous nephropathy: When and how to treat
Renin-stimulated TGF-β1 expression is regulated by a mitogen-activated protein kinase in mesangial cells  Y. Huang, N.A. Noble, J. Zhang, C. Xu, W.A.
Volume 72, Issue 7, Pages (October 2007)
Volume 64, Issue 6, Pages (December 2003)
Autoradiographic mapping and characterization of insulin-like growth factor-I receptor binding in human greater saphenous vein  Anton N. Sidawy, MD, Fares.
Volume 61, Issue 3, Pages (March 2002)
Volume 58, Issue 4, Pages (October 2000)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Is there a pharmacologic basis for combination renin axis blockade?
Volume 74, Issue 12, Pages (December 2008)
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency  Fiona E. Mackie, Timothy W. Meyer,
Volume 58, Issue 6, Pages (December 2000)
Volume 74, Issue 2, Pages (July 2008)
Hyaluronan increases glomerular cyclooxygenase-2 protein expression in a p38 MAP- kinase–dependent process  Marjorie E. Dunlop, Ph.D., Evelyne E. Muggli 
Wei-Zhong Ying, Paul W. Sanders  Kidney International 
Volume 64, Issue 4, Pages (October 2003)
Volume 60, Issue 1, Pages (July 2001)
Volume 60, Issue 6, Pages (December 2001)
Volume 66, Issue 4, Pages (October 2004)
Volume 62, Issue 6, Pages (December 2002)
Role and regulation of activation of caspases in cisplatin-induced injury to renal tubular epithelial cells  Gur P. Kaushal, Varsha Kaushal, Ph.D., Xiaoman.
Transport of thiamin in rat renal brush border membrane vesicles
Volume 62, Issue 2, Pages (August 2002)
STAT proteins mediate angiotensin II–induced production of TIMP-1 in human proximal tubular epithelial cells  Xiangmei Chen, Jianzhong Wang, Feng Zhou,
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 64, Pages S33-S38 (October 2003)
Angiotensin II production and distribution in the kidney – II
Volume 61, Issue 5, Pages (May 2002)
Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation  Xi-Ping Ni, Massy Safai, David G. Gardner,
Volume 58, Issue 2, Pages (August 2000)
Angiotensin II stimulates Pax-2 in rat kidney proximal tubular cells: Impact on proliferation and apoptosis  Shao-Ling Zhang, Jun Guo, Babak Moini, Julie.
Ho Jae Han, Soo Hyun Park, Hyun Ju Koh, Mary Taub  Kidney International 
H+-ATPase activity on unilateral ureteral obstruction: Interaction of endogenous nitric oxide and angiotensin II  Patricia G. Valles, Walter A. Manucha 
Ken Inoki, Masakazu Haneda, Shiro Maeda, Daisuke Koya, Ryuichi Kikkawa 
Volume 57, Issue 2, Pages (October 2000)
Volume 61, Issue 6, Pages (June 2002)
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Volume 62, Issue 6, Pages (December 2002)
Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue- type plasminogen activator  Thomas Sitter, Karin Toet, Paul.
Barbara A. Bresnahan, Shelly Dufek, Shenghua Wu, Elias A. Lianos, M.D. 
Volume 55, Issue 6, Pages (June 1999)
Structure and receptor-binding properties of SCH-C.
Regulation of human renin gene promoter activity: A new negative regulatory region determines the responsiveness to TNFα  Ling-Sing K. Chen, Michael P.
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Volume 68, Issue 5, Pages (November 2005)
Is it the low-protein diet or simply the salt restriction?
Volume 55, Issue 6, Pages (June 1999)
Volume 65, Issue 4, Pages (April 2004)
Volume 61, Issue 6, Pages (June 2002)
Volume 62, Issue 4, Pages (October 2002)
Volume 65, Issue 3, Pages (March 2004)
Volume 55, Issue 4, Pages (April 1999)
Volume 58, Issue 6, Pages (December 2000)
Volume 61, Issue 1, Pages (January 2002)
Dr Inka Leier, Johanna Hummel-Eisenbeiss, Yunhai Cui, Dietrich Keppler 
Volume 61, Issue 5, Pages (May 2002)
Presentation transcript:

Volume 59, Issue 5, Pages 1881-1890 (May 2001) Coordinate regulation of canine glomeruli and adrenal angiotensin receptors by dietary sodium manipulation  Wei Zheng, Hong Ji, Zsolt Szabo, Phillip R. Brown, Sung-Eun Yoo, Kathryn Sandberg  Kidney International  Volume 59, Issue 5, Pages 1881-1890 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051881.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effect of dietary sodium manipulation on parameters of the renin-angiotensin system (RAS). Blood was removed from animals in the High salt (□) and Low salt (▪) groups and analyzed for plasma levels of renin (A), Ang II (B), aldosterone (C), and corticosterone (D). Data are expressed as the means ± SEM from assays performed in triplicate. N = 4 per group. Kidney International 2001 59, 1881-1890DOI: (10.1046/j.1523-1755.2001.0590051881.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 125I-[Sar1,Ile8]Ang II binding to kidney and adrenal canine angiotensin II subtype 1 (cAT1) receptors. (A) Time course. Isolated kidney glomeruli (•) and membranes prepared from renal medulla (▪) and the adrenal gland (○) were incubated for different times with 500 pmol/L 125I-[Sar1,Ile8]Ang II at 27°C. Values are the means ± SEM from three independent experiments performed in duplicate. (B) Dose response curve. Isolated kidney glomeruli (•) and membranes prepared from the renal medulla (▪) and adrenal gland (○) were incubated with 500 pmol/L 125I-[Sar1,Ile8]Ang II and increasing concentrations of membranes ranging from 5 to 30 μg protein per sample for 120 minutes at 27°C. Values are the means ± SEM from three independent experiments performed in triplicate. Kidney International 2001 59, 1881-1890DOI: (10.1046/j.1523-1755.2001.0590051881.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Competition binding profiles of angiotensin ligands for dog AT receptors expressed in kidney and adrenal tissues. The binding profiles of Ang II (○), L-163,017 (▴), SK31080 (•), losartan (□), and PD-123,319 (♦) are shown for isolated kidney glomeruli (A), and membranes prepared from renal medulla (B) and the adrenal gland (C). Samples were incubated with 500 pmol/L 125I-[Sar1,Ile8]Ang II and increasing concentrations of unlabeled competitor ligands. The x axis represents the log concentration (mol/L) of unlabeled competitor ligands, and the y axis represents the binding expressed as a percentage of the specific binding obtained in the absence of competitor. Each point represents the mean of specific binding data from three separate experiments carried out in triplicate. (Inset) The binding profile of PD-123,319 for adrenal membranes under conditions in which all the cAT1 receptors are blocked with losartan (10 μmol/L) is shown. Kidney International 2001 59, 1881-1890DOI: (10.1046/j.1523-1755.2001.0590051881.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Saturation analysis of dog AT receptors expressed in kidney and adrenal tissues. Saturation curves of AT receptors for isolated kidney glomeruli (A), and membranes prepared from renal medulla (B) and the adrenal gland (C and D). Samples were incubated with increasing concentrations of 125I-[Sar1,Ile8]Ang II in the presence of saturating concentrations of the AT2 receptor blocker PD-123,319 in the presence and absence of 200 nmol/L Ang II. Symbols are: (▪ high salt; (▴) low salt. The x axis represents the concentration (nmol/L) of [Sar1,Ile8]-Ang II, and the y axis represents the percentage specific binding. Each point represents the mean of specific binding data from three separate experiments carried out in duplicate. (Insets) Scatchard plots from saturation binding data are shown. Kidney International 2001 59, 1881-1890DOI: (10.1046/j.1523-1755.2001.0590051881.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Shown are cAT1 and cAT2 receptor Bmax values calculated from Scatchard plots for isolated kidney glomeruli and membranes prepared from renal medulla and the adrenal gland in the high-salt (H; □) and low-salt (L; ▪) animal groups. Data are expressed as the means ± SEM of Bmax values determined from Scatchard plots as in Figure 4. N = 6 per group. Kidney International 2001 59, 1881-1890DOI: (10.1046/j.1523-1755.2001.0590051881.x) Copyright © 2001 International Society of Nephrology Terms and Conditions